Structure-Based Drug Design with a Special Emphasis
on Herbal Extracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
D. Velmurugan, N. H. V. Kutumbarao, V. Viswanathan
and Atanu Bhattacharjee
Impact of Target-Based Drug Design in Anti-bacterial Drug
Discovery for the Treatment of Tuberculosis . . . . . . . . . . . . . . . . . . . . . 307
Anju Choorakottayil Pushkaran, Raja Biswas and C. Gopi Mohan
Turbo Analytics: Applications of Big Data and HPC
in Drug Discovery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 347
Rajendra R. Joshi, Uddhavesh Sonavane, Vinod Jani, Amit Saxena,
Shruti Koulgi, Mallikarjunachari Uppuladinne, Neeru Sharma,
Sandeep Malviya, E. P. Ramakrishnan, Vivek Gavane, Avinash Bayaskar,
Rashmi Mahajan and Sudhir Pandey
Single-Particle cryo-EM as a Pipeline for Obtaining Atomic
Resolution Structures of Druggable Targets in Preclinical
Structure-Based Drug Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375
Ramanathan Natesh
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401
viii
Contents
on Herbal Extracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
D. Velmurugan, N. H. V. Kutumbarao, V. Viswanathan
and Atanu Bhattacharjee
Impact of Target-Based Drug Design in Anti-bacterial Drug
Discovery for the Treatment of Tuberculosis . . . . . . . . . . . . . . . . . . . . . 307
Anju Choorakottayil Pushkaran, Raja Biswas and C. Gopi Mohan
Turbo Analytics: Applications of Big Data and HPC
in Drug Discovery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 347
Rajendra R. Joshi, Uddhavesh Sonavane, Vinod Jani, Amit Saxena,
Shruti Koulgi, Mallikarjunachari Uppuladinne, Neeru Sharma,
Sandeep Malviya, E. P. Ramakrishnan, Vivek Gavane, Avinash Bayaskar,
Rashmi Mahajan and Sudhir Pandey
Single-Particle cryo-EM as a Pipeline for Obtaining Atomic
Resolution Structures of Druggable Targets in Preclinical
Structure-Based Drug Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375
Ramanathan Natesh
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401
viii
Contents
